The treatment of idiopathic membranous nephropathy is heavily debated because of wide variation in outcome. A rational treatment strategy is needed to appropriately administer conservative treatment to the low-risk group but immunosuppressive therapy to those with medium or high risk of renal deterioration. Currently, combinations of steroids with alkylating agents are best studied. Newer forms of immunosuppressive treatment are currently under study
Background/PurposeImmunosuppressive therapy plays an important role in patients with high-risk idiop...
Therapy for idiopathic membranous nephropathy: Tailoring the choice by decision analysis. Two Italia...
Immunosuppressive therapy plays an important role in patients with high-risk idiopathic membranous n...
The treatment of idiopathic membranous nephropathy is heavily debated because of wide variation in o...
Idiopathic membranous nephropathy is a common cause of nephrotic syndrome. The treatment of patients...
Treatment of idiopathic membranous nephropathy is based on a 'symptomatic' therapy that includes ACE...
Immunosuppressive treatment of patients with idiopathic membranous nephropathy (iMN) is heavily deba...
Immunosuppressive treatment of patients with idiopathic membranous nephropathy (IMN) is debated due ...
Idiopathic membranous nephropathy (iMN) is a common cause of the nephrotic syndrome in adults. A nep...
Idiopathic membranous nephropathy is the most common cause of nephrotic syndrome. In patients who pr...
Management of idiopathic membranous nephropathy: Evidence-based recommendations. Membranous nephropa...
Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy.B...
Recently published Kidney Disease Improving Global Outcomes (KDIGO) guidelines recommend limiting th...
BACKGROUND: Immunosuppressive treatment initiated at an early stage in patients with idiopathic memb...
Background : The introduction of renin angiotensin system blockers (RASB) might challenge the previo...
Background/PurposeImmunosuppressive therapy plays an important role in patients with high-risk idiop...
Therapy for idiopathic membranous nephropathy: Tailoring the choice by decision analysis. Two Italia...
Immunosuppressive therapy plays an important role in patients with high-risk idiopathic membranous n...
The treatment of idiopathic membranous nephropathy is heavily debated because of wide variation in o...
Idiopathic membranous nephropathy is a common cause of nephrotic syndrome. The treatment of patients...
Treatment of idiopathic membranous nephropathy is based on a 'symptomatic' therapy that includes ACE...
Immunosuppressive treatment of patients with idiopathic membranous nephropathy (iMN) is heavily deba...
Immunosuppressive treatment of patients with idiopathic membranous nephropathy (IMN) is debated due ...
Idiopathic membranous nephropathy (iMN) is a common cause of the nephrotic syndrome in adults. A nep...
Idiopathic membranous nephropathy is the most common cause of nephrotic syndrome. In patients who pr...
Management of idiopathic membranous nephropathy: Evidence-based recommendations. Membranous nephropa...
Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy.B...
Recently published Kidney Disease Improving Global Outcomes (KDIGO) guidelines recommend limiting th...
BACKGROUND: Immunosuppressive treatment initiated at an early stage in patients with idiopathic memb...
Background : The introduction of renin angiotensin system blockers (RASB) might challenge the previo...
Background/PurposeImmunosuppressive therapy plays an important role in patients with high-risk idiop...
Therapy for idiopathic membranous nephropathy: Tailoring the choice by decision analysis. Two Italia...
Immunosuppressive therapy plays an important role in patients with high-risk idiopathic membranous n...